Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
This grant funds partnerships between bioengineering researchers and industry to advance clinical applications.
About this program
The Bioengineering Partnerships with Industry (U01 Clinical Trial Optional) grant aims to foster collaborations between academic bioengineering researchers and industry partners. The goal is to translate innovative bioengineering solutions into clinical applications that can improve patient care and health outcomes. This grant is designed for research institutions and industry stakeholders who are looking to work together on projects that bridge the gap between laboratory research and practical implementation in healthcare settings. Eligible applicants include universities, research institutions, and industry partners that can demonstrate a commitment to advancing bioengineering technologies. The grant encourages the development of new methodologies, tools, and technologies that can be utilized in clinical settings. By supporting these partnerships, the program seeks to enhance the effectiveness of bioengineering research and its impact on healthcare delivery.
Eligibility
Research institutions and industry partners involved in bioengineering.